Fifth Third Bancorp
COLL icon

Fifth Third Bancorp’s Collegium Pharmaceutical COLL Stock Holding History

Fifth Third Bancorp’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.05M Sell
28,983
-109
-0.4% -$3.73K ﹤0.01% 1654
2026
Q1 		$962K Buy
29,092
+28,913
+16,153% +$1.22M ﹤0.01% 1664
2025
Q4 		$8.29K Buy
179
+11
+7% +$460 ﹤0.01% 2186
2025
Q3 		$5.88K Buy
168
+57
+51% +$1.98K ﹤0.01% 2290
2025
Q2 		$3.28K Buy
111
+6
+6% +$171 ﹤0.01% 2284
2025
Q1 		$3.13K Buy
105
+32
+44% +$978 ﹤0.01% 2283
2024
Q4 		$2.09K Sell
73
-1
-1% -$33 ﹤0.01% 2313
2024
Q3 		$2.86K Buy
74
+4
+6% +$143 ﹤0.01% 2300
2024
Q2 		$2.25K Buy
70
+17
+32% +$589 ﹤0.01% 2252
2024
Q1 		$2.06K Buy
53
+5
+10% +$175 ﹤0.01% 2213
2023
Q4 		$1.48K Hold
48
– – ﹤0.01% 2375
2023
Q3 		$1.07K Hold
48
– – ﹤0.01% 2454
2023
Q2 		$1.03K Sell
48
-602
-93% -$13.7K ﹤0.01% 2507
2023
Q1 		$15.6K Buy
650
+602
+1,254% +$16K ﹤0.01% 1917
2022
Q4 		$1.11K Hold
48
– – ﹤0.01% 2520
2022
Q3 		$1K Hold
48
– – ﹤0.01% 2526
2022
Q2 		$1K Buy
+48
New +$807 ﹤0.01% 2509

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Fifth Third Bancorp's COLL Position: Q2 2026 in Review

Fifth Third Bancorp reduced its Collegium Pharmaceutical (COLL) stake by 0.37% in Q2 2026, selling an estimated $3.73K and leaving 28,983 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #1654.

Fifth Third Bancorp first reported a position in COLL in Q2 2022 and has held it in 17 quarters since. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Fifth Third Bancorp held 28,983 shares of Collegium Pharmaceutical worth $1.05M as of Q2 2026.
  • Fifth Third Bancorp sold 109 Collegium Pharmaceutical shares in Q2 2026, an estimated $3.73K.
  • Collegium Pharmaceutical made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #1654 holding.
  • Fifth Third Bancorp first reported a position in Collegium Pharmaceutical in Q2 2022 and has held it in 17 quarters since.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.